期刊文献+

Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromised patients 被引量:3

Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromised patients
下载PDF
导出
摘要 AIM:To investigate the utility of the cytomegalovirus(CMV)antigenemia assay for the diagnosis of CMV gastrointestinal disease(GID). METHODS:One hundred and thirty immunocompromised patients were enrolled in this study.Patients with a history of anti-CMV treatment and who had not undergone examination using the antigenemia assay were excluded.CMV-GID was defined as the detection of large cells with intranuclear inclusions alone or associated with granular cytoplasmic inclusions by biopsy.Biopsy sections were stained with hematoxylin and eosin and immunohistochemically stained with anti-CMV.We evaluated the association between CMV-GID and patient characteristics(symptoms,underlying disease,medication,leukocyte counts,and antigenemia assay).All patients were checked with an human immunodeficiency virus(HIV)antibody test before endoscopic examination.White blood cell(WBC)counts were obtained from medical records within 1 wk of endoscopy.Leukopenia was defined as a total WBC count<5000 cells/mm 3 . For HIV patients,we also checked CD4+counts from medical records. RESULTS:A total of 99 patients were retrospectively selected for analysis.Of the immunocompromised patients,19 had malignant disease,18 had autoimmune disease,19 had disorders of biochemical homeostasis, three had undergone transplantation,and 45 had HIV infection.A total of 50 patients had received immunosuppressive therapy.No patients had inflammatory bowel disease.Fifty-five patients were diagnosed as having CMV-GID.Univariate analysis indicated an association between HIV infection,leukopenia,and positive antigenemia and CMV-GID(P<0.05).Multivariate analysis using logistic regression revealed that HIV infection and positive antigenemia were the only independent factors related to CMV-GID(P<0.01).The sensitivity,specificity,positive predictive value,and negative predictive value of antigenemia for CMV-GID were 65.4%,93.6%, 91.9%,and 71.0%,respectively.In a subgroup analy-sis,patients with leukopenia displayed low sensitivity and high specificity.Minimal differences in accuracy were seen among patients with or without leukopenia. HIV-infected patients displayed low sensitivity and high specificity.Accuracy barely differed between HIV-positive and-negative patients.In HIV-infected patients, CD4 count<50 cells/μL resulted in low sensitivity and high specificity.Differences in accuracy among patients were minor,regardless of CD4 count.In patients who had undergone both quantitative real-time polymerase chain reaction(PCR)and antigenemia assay,real-time PCR was slightly more accurate in terms of sensitivity than the antigenemia assay;however,this difference was not statistically significant(P=0.312). CONCLUSION:If the antigenemia test is positive,endoscopic lesions are acceptable for the diagnosis of CMVGID without biopsy.The accuracy is not affected by HIV infection and leukopenia.Either PCR or the antigenemia assay are valid. AIM:To investigate the utility of the cytomegalovirus(CMV)antigenemia assay for the diagnosis of CMV gastrointestinal disease(GID). METHODS:One hundred and thirty immunocompromised patients were enrolled in this study.Patients with a history of anti-CMV treatment and who had not undergone examination using the antigenemia assay were excluded.CMV-GID was defined as the detection of large cells with intranuclear inclusions alone or associated with granular cytoplasmic inclusions by biopsy.Biopsy sections were stained with hematoxylin and eosin and immunohistochemically stained with anti-CMV.We evaluated the association between CMV-GID and patient characteristics(symptoms,underlying disease,medication,leukocyte counts,and antigenemia assay).All patients were checked with an human immunodeficiency virus(HIV)antibody test before endoscopic examination.White blood cell(WBC)counts were obtained from medical records within 1 wk of endoscopy.Leukopenia was defined as a total WBC count5000 cells/mm 3 . For HIV patients,we also checked CD4+counts from medical records. RESULTS:A total of 99 patients were retrospectively selected for analysis.Of the immunocompromised patients,19 had malignant disease,18 had autoimmune disease,19 had disorders of biochemical homeostasis, three had undergone transplantation,and 45 had HIV infection.A total of 50 patients had received immunosuppressive therapy.No patients had inflammatory bowel disease.Fifty-five patients were diagnosed as having CMV-GID.Univariate analysis indicated an association between HIV infection,leukopenia,and positive antigenemia and CMV-GID(P0.05).Multivariate analysis using logistic regression revealed that HIV infection and positive antigenemia were the only independent factors related to CMV-GID(P0.01).The sensitivity,specificity,positive predictive value,and negative predictive value of antigenemia for CMV-GID were 65.4%,93.6%, 91.9%,and 71.0%,respectively.In a subgroup analy-sis,patients with leukopenia displayed low sensitivity and high specificity.Minimal differences in accuracy were seen among patients with or without leukopenia. HIV-infected patients displayed low sensitivity and high specificity.Accuracy barely differed between HIV-positive and-negative patients.In HIV-infected patients, CD4 count50 cells/μL resulted in low sensitivity and high specificity.Differences in accuracy among patients were minor,regardless of CD4 count.In patients who had undergone both quantitative real-time polymerase chain reaction(PCR)and antigenemia assay,real-time PCR was slightly more accurate in terms of sensitivity than the antigenemia assay;however,this difference was not statistically significant(P=0.312). CONCLUSION:If the antigenemia test is positive,endoscopic lesions are acceptable for the diagnosis of CMVGID without biopsy.The accuracy is not affected by HIV infection and leukopenia.Either PCR or the antigenemia assay are valid.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第9期1185-1191,共7页 世界胃肠病学杂志(英文版)
关键词 免疫功能低下 巨细胞病毒 抗原检测 诊断价值 患者 免疫组织化学染色 艾滋病毒感染 Logistic回归 Cytomegalovirus Gastrointestinal disease Antigenemia assay Real-time polymerase chain reaction Human immunodeficiency virus infection
  • 相关文献

参考文献26

  • 1Goodgame RW. Gastrointestinal cytomegalovirus disease. Ann Intern Med 1993; 119:924-935.
  • 2Baroco AL, Oldfield EC. Gastrointestinal cytomegalovirus disease in the immunocompromised patient. Curr Gastroen- terol Rep 2008; 10:409-416.
  • 3Mori T, Mori S, Kanda Y, Yakushiji K, Mineishi S, Takaue Y, Gondo H, Harada M, Sakamaki H, Yajima T, Iwao Y, Hibi T, Okamoto S. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gas- trointestinal disease after allogeneic hematopoietic stern cell transplantation. Bone Marrow Transplant 2004; 33:431-434.
  • 4Whitley RJ, Jacobson MA, Friedberg DN, Holland GN, Jabs DA, Dieterich DT, Hardy WD, Polis MA, Deutsch TA, Fein- berg J, Spector SA, Walmsley S, Drew WL, Powderly WG, Griffiths PD, Benson CA, Kessler HA. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med 1998; 158:957-969.
  • 5Fujita M, Hatachi S, Yagita M. Immunohistochemically proven cytomegalovirus gastrointestinal diseases in three patients with autoimmune diseases. Clin Rheumatol 2008; 27: 1057-1059.
  • 6Sultan SM, Ioannou Y, Isenberg DA. A review of gastrointes- tinal manifestations of systemic lupus erythematosus. Rheu- matology (Oxford) 1999; 38:917-932.
  • 7Falagas ME, Griffiths J, Prekezes J, Worthington M. Cyto- megalovirus colitis mimicking colon carcinoma in an HW- negative patient with chronic renal failure. Am J Gastroenterol 1996; 91:168-169.
  • 8Galiatsatos P, Shrier I, Lamoureux E, Szilagyi A. Meta-anal- ysis of outcome of cytomegalovirus colitis in immunocompe- tent hosts. Dig Dis Sci 2005; 50:609-616.
  • 9Toogood GJ, Gillespie PH, Gujral S, Warren BF, Roake JA, Gray DW, Morris PJ. Cytomegalovirus infection and colonic perfora- tion in renal transplant patients. Transpl Int 1996; 9:248-251.
  • 10Almeida N, Romaozinho JM, Amaro P, Ferreira M, Cipriano MA, Leitao MC. Fatal mid-gastrointestinal bleeding by cyto- megalovirus enteritis in an immunocompetent patient. Acta Gastroenterol Belg 2009; 72:245-248.

同被引文献24

  • 1Hideyuki Suzuki,Jun Kato,Motoaki Kuriyama,Sakiko Hiraoka,Kenji Kuwaki,Kazuhide Yamamoto.Specific endoscopic features of ulcerative colitis complicated by cytomegalovirus infection[J].World Journal of Gastroenterology,2010,16(10):1245-1251. 被引量:19
  • 2Masaaki Minami,Michio Ohta,Teruko Ohkura,Takafumi Ando,Naoki Ohmiya,Yasumasa Niwa,Hidemi Goto.Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan[J].World Journal of Gastroenterology,2007,13(5):754-760. 被引量:15
  • 3Axel Dignass,Rami Eliakim,Fernando Magro,Christian Maaser,Yehuda Chowers,Karel Geboes,Gerassimos Mantzaris,Walter Reinisch,Jean-Frederic Colombel,Severine Vermeire,Simon Travis,James O. Lindsay,Gert Van Assche.Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis[J].Journal of Crohn’s and Colitis.2012(10)
  • 4Axel Dignass,James O. Lindsay,Andreas Sturm,Alastair Windsor,Jean-Frederic Colombel,Mathieu Allez,Gert D’Haens,André D’Hoore,Gerassimos Mantzaris,Gottfried Novacek,Tom ?resland,Walter Reinisch,Miquel Sans,Eduard Stange,Severine Vermeire,Simon Travis,Gert Van Assche.Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management[J].Journal of Crohn’s and Colitis.2012(10)
  • 5Sylvie Pillet,Bruno Pozzetto,Camille Jarlot,Stéphane Paul,Xavier Roblin.Management of cytomegalovirus infection in inflammatory bowel diseases[J].Digestive and Liver Disease.2012(7)
  • 6Minh Nguyen,Kara Bradford,Xiaolan Zhang,David Q. Shih,T. Arakawa.Cytomegalovirus Reactivation in Ulcerative Colitis Patients[J].Ulcers.2011
  • 7GarrettLawlor,Alan C.Moss.Cytomegalovirus in inflammatory bowel disease: Pathogen or innocent bystander?[J].Inflamm Bowel Dis.2010(9)
  • 8J.F. Rahier,S. Ben-Horin,Y. Chowers,C. Conlon,P. De Munter,G. D’Haens,E. Domènech,R. Eliakim,A. Eser,J. Frater,M. Gassull,M. Giladi,A. Kaser,M. Lémann,T. Moreels,A. Moschen,R. Pollok,W. Reinisch,M. Schunter,E.F. Stange,H. Tilg,G. Van Assche,N. Viget,B. Vucelic,A. Walsh,G. Weiss,Y. Yazdanpanah,Y. Zabana,S.P.L. Travis,J.F. Colombel.European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease[J].Journal of Crohn’s and Colitis.2009(2)
  • 9Inger Camilla Solberg,Idar Lygren,J?rgen Jahnsen,Erling Aadland,Ole H?ie,Milada Cvancarova,Tomm Bernklev,Magne Henriksen,Jostein Sauar,Morten H. Vatn,Bj?rn Moum,And the IBSEN Study Group.Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)[J].Scandinavian Journal of Gastroenterology.2009(4)
  • 10Dani?l W.Hommes,GerbenSterringa,Sander J. H.van Deventer,Guido N. J.Tytgat,JanWeel.The pathogenicity of cytomegalovirus in inflammatory bowel disease. A systematic review and evidence‐based recommendations for future research[J].Inflamm Bowel Dis.2006(3)

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部